David Bentley
Concepts (441)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA Polymerase II | 60 | 2025 | 317 | 11.420 |
Why?
| Transcription, Genetic | 61 | 2025 | 1416 | 7.030 |
Why?
| RNA Precursors | 17 | 2023 | 148 | 4.540 |
Why?
| RNA, Messenger | 35 | 2021 | 2702 | 4.020 |
Why?
| RNA Processing, Post-Transcriptional | 16 | 2021 | 88 | 3.730 |
Why?
| Transcription Termination, Genetic | 5 | 2025 | 19 | 3.550 |
Why?
| RNA Splicing | 17 | 2023 | 259 | 2.630 |
Why?
| Transcription Elongation, Genetic | 6 | 2018 | 22 | 2.370 |
Why?
| Saccharomyces cerevisiae Proteins | 13 | 2017 | 383 | 2.290 |
Why?
| Nuclear Proteins | 13 | 2025 | 660 | 2.290 |
Why?
| RNA-Binding Proteins | 12 | 2025 | 388 | 2.240 |
Why?
| Histones | 9 | 2018 | 588 | 1.860 |
Why?
| Poly A | 9 | 2022 | 48 | 1.810 |
Why?
| Transcriptional Elongation Factors | 6 | 2022 | 36 | 1.720 |
Why?
| Saccharomyces cerevisiae | 12 | 2022 | 530 | 1.710 |
Why?
| Protein Phosphatase 1 | 2 | 2025 | 33 | 1.590 |
Why?
| Exoribonucleases | 4 | 2019 | 43 | 1.530 |
Why?
| Cyclin-Dependent Kinases | 9 | 2025 | 126 | 1.400 |
Why?
| Alternative Splicing | 8 | 2021 | 216 | 1.380 |
Why?
| DNA-Binding Proteins | 11 | 2025 | 1441 | 1.300 |
Why?
| Promoter Regions, Genetic | 16 | 2024 | 1213 | 1.290 |
Why?
| RNA 3' End Processing | 6 | 2018 | 11 | 1.290 |
Why?
| HEK293 Cells | 10 | 2025 | 697 | 1.160 |
Why?
| mRNA Cleavage and Polyadenylation Factors | 7 | 2018 | 27 | 1.050 |
Why?
| Chromatin | 8 | 2017 | 478 | 0.970 |
Why?
| Transcriptional Activation | 5 | 2018 | 366 | 0.930 |
Why?
| RNA | 7 | 2021 | 876 | 0.920 |
Why?
| Protein Processing, Post-Translational | 4 | 2019 | 457 | 0.920 |
Why?
| Phosphorylation | 16 | 2025 | 1716 | 0.900 |
Why?
| RNA Caps | 8 | 2014 | 33 | 0.850 |
Why?
| Polyadenylation | 3 | 2022 | 40 | 0.850 |
Why?
| Transcription Factor TFIIH | 6 | 2020 | 37 | 0.720 |
Why?
| Transcription Initiation, Genetic | 2 | 2018 | 15 | 0.700 |
Why?
| HeLa Cells | 11 | 2025 | 611 | 0.640 |
Why?
| Cell Line | 17 | 2025 | 2779 | 0.630 |
Why?
| Transcription Factors | 13 | 2012 | 1645 | 0.630 |
Why?
| DNA, Fungal | 2 | 2017 | 75 | 0.630 |
Why?
| Chromatin Assembly and Disassembly | 3 | 2017 | 99 | 0.620 |
Why?
| Introns | 5 | 2023 | 249 | 0.620 |
Why?
| RNA Cleavage | 1 | 2018 | 10 | 0.610 |
Why?
| Models, Genetic | 8 | 2015 | 592 | 0.610 |
Why?
| Yeasts | 5 | 2011 | 52 | 0.560 |
Why?
| Nucleosomes | 2 | 2011 | 137 | 0.530 |
Why?
| RNA, Catalytic | 2 | 2009 | 185 | 0.530 |
Why?
| Cell Nucleus | 6 | 2022 | 590 | 0.520 |
Why?
| Kinetics | 6 | 2019 | 1645 | 0.510 |
Why?
| Methyltransferases | 3 | 2004 | 70 | 0.510 |
Why?
| Mutation | 18 | 2018 | 3705 | 0.510 |
Why?
| Recombinant Fusion Proteins | 4 | 2016 | 650 | 0.490 |
Why?
| Transcription Factors, TFII | 5 | 2012 | 40 | 0.470 |
Why?
| Protein Engineering | 1 | 2016 | 106 | 0.470 |
Why?
| Exons | 11 | 2021 | 341 | 0.460 |
Why?
| DNA Polymerase II | 3 | 2005 | 38 | 0.450 |
Why?
| RNA, Fungal | 2 | 2011 | 67 | 0.450 |
Why?
| Binding Sites | 11 | 2019 | 1251 | 0.450 |
Why?
| Terminator Regions, Genetic | 5 | 2006 | 12 | 0.440 |
Why?
| Exonucleases | 2 | 2022 | 8 | 0.430 |
Why?
| Polymerase Chain Reaction | 3 | 2016 | 1033 | 0.420 |
Why?
| Genes, myc | 5 | 2007 | 47 | 0.420 |
Why?
| Protein Binding | 7 | 2025 | 2122 | 0.420 |
Why?
| RNA Stability | 2 | 2012 | 103 | 0.410 |
Why?
| Oocytes | 10 | 2005 | 170 | 0.410 |
Why?
| Nucleotidyltransferases | 4 | 2004 | 27 | 0.410 |
Why?
| Humans | 69 | 2025 | 129687 | 0.400 |
Why?
| Protein Kinases | 3 | 2010 | 318 | 0.390 |
Why?
| Genes, Fungal | 2 | 2010 | 50 | 0.390 |
Why?
| Gene Expression Regulation, Fungal | 4 | 2017 | 68 | 0.380 |
Why?
| Protein Structure, Tertiary | 10 | 2015 | 844 | 0.370 |
Why?
| Phosphoprotein Phosphatases | 2 | 2009 | 67 | 0.360 |
Why?
| Fungal Proteins | 5 | 2011 | 130 | 0.350 |
Why?
| Animals | 37 | 2024 | 35404 | 0.350 |
Why?
| Phosphoserine | 1 | 2010 | 34 | 0.350 |
Why?
| Neoplasm Proteins | 3 | 2007 | 417 | 0.330 |
Why?
| Dichlororibofuranosylbenzimidazole | 6 | 2009 | 8 | 0.320 |
Why?
| Histone-Lysine N-Methyltransferase | 3 | 2017 | 124 | 0.320 |
Why?
| RNA Folding | 2 | 2021 | 36 | 0.310 |
Why?
| Spliceosomes | 3 | 2023 | 46 | 0.310 |
Why?
| Genes, Regulator | 3 | 2004 | 35 | 0.300 |
Why?
| RNA Splice Sites | 3 | 2021 | 44 | 0.290 |
Why?
| Molecular Sequence Data | 14 | 2014 | 2833 | 0.280 |
Why?
| Repressor Proteins | 3 | 2014 | 404 | 0.270 |
Why?
| Ubiquitination | 2 | 2024 | 98 | 0.250 |
Why?
| Macromolecular Substances | 5 | 2010 | 216 | 0.250 |
Why?
| Peptide Elongation Factors | 2 | 2022 | 15 | 0.240 |
Why?
| Cyclin-Dependent Kinase 8 | 1 | 2025 | 43 | 0.230 |
Why?
| Lysine | 1 | 2007 | 286 | 0.230 |
Why?
| RNA Cap-Binding Proteins | 1 | 2004 | 4 | 0.220 |
Why?
| DNA-Directed RNA Polymerases | 2 | 1997 | 54 | 0.220 |
Why?
| RNA Polymerase III | 2 | 2017 | 26 | 0.220 |
Why?
| RNA Editing | 3 | 2009 | 20 | 0.210 |
Why?
| Interferons | 1 | 2025 | 189 | 0.210 |
Why?
| Methylation | 3 | 2011 | 228 | 0.210 |
Why?
| Amino Acid Sequence | 9 | 2014 | 2057 | 0.200 |
Why?
| Models, Biological | 5 | 2020 | 1724 | 0.200 |
Why?
| RNA, Antisense | 1 | 2022 | 16 | 0.200 |
Why?
| Gene Expression Regulation | 8 | 2025 | 2545 | 0.200 |
Why?
| Chromatin Immunoprecipitation | 3 | 2012 | 132 | 0.200 |
Why?
| Ovarian Neoplasms | 4 | 2013 | 482 | 0.200 |
Why?
| Signal Transduction | 5 | 2025 | 4935 | 0.200 |
Why?
| Models, Theoretical | 1 | 2006 | 549 | 0.200 |
Why?
| Nucleotides | 1 | 2022 | 122 | 0.190 |
Why?
| Ultraviolet Rays | 2 | 2018 | 383 | 0.180 |
Why?
| Gene Products, tat | 2 | 1998 | 22 | 0.180 |
Why?
| Chromosomal Proteins, Non-Histone | 2 | 2003 | 116 | 0.180 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 1327 | 0.180 |
Why?
| Mice | 13 | 2018 | 16982 | 0.180 |
Why?
| HCT116 Cells | 2 | 2018 | 76 | 0.170 |
Why?
| Protein Kinase Inhibitors | 2 | 2025 | 886 | 0.170 |
Why?
| Proto-Oncogenes | 3 | 1989 | 29 | 0.170 |
Why?
| Base Sequence | 12 | 2007 | 2142 | 0.170 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 2 | 2014 | 60 | 0.170 |
Why?
| Transfection | 7 | 2007 | 918 | 0.170 |
Why?
| HIV-2 | 2 | 1997 | 18 | 0.170 |
Why?
| Xenopus | 6 | 2003 | 84 | 0.170 |
Why?
| Genome, Human | 3 | 2015 | 393 | 0.160 |
Why?
| Adenosine Triphosphatases | 2 | 2012 | 161 | 0.160 |
Why?
| Peptide Chain Elongation, Translational | 2 | 1998 | 18 | 0.160 |
Why?
| 3' Flanking Region | 1 | 2018 | 7 | 0.160 |
Why?
| Glyceraldehyde-3-Phosphate Dehydrogenases | 2 | 2009 | 13 | 0.150 |
Why?
| Hydrolysis | 2 | 2011 | 186 | 0.150 |
Why?
| Phenanthrenes | 1 | 2018 | 12 | 0.150 |
Why?
| Metallothionein | 1 | 1998 | 25 | 0.150 |
Why?
| Diterpenes | 1 | 2018 | 31 | 0.150 |
Why?
| Epoxy Compounds | 1 | 2018 | 33 | 0.150 |
Why?
| Isotonic Solutions | 1 | 2018 | 37 | 0.150 |
Why?
| Coenzymes | 1 | 1998 | 20 | 0.150 |
Why?
| Saline Solution, Hypertonic | 1 | 2018 | 40 | 0.150 |
Why?
| Down Syndrome | 1 | 2025 | 478 | 0.150 |
Why?
| Zebrafish Proteins | 1 | 2001 | 268 | 0.140 |
Why?
| Genes | 5 | 2004 | 225 | 0.140 |
Why?
| Cell Cycle Proteins | 3 | 2003 | 583 | 0.140 |
Why?
| 3' Untranslated Regions | 3 | 2022 | 138 | 0.140 |
Why?
| Serine | 3 | 2009 | 137 | 0.140 |
Why?
| Enzyme Inhibitors | 2 | 2003 | 827 | 0.140 |
Why?
| Progestins | 1 | 2017 | 78 | 0.130 |
Why?
| Trans-Activators | 2 | 2002 | 392 | 0.130 |
Why?
| Xenopus laevis | 4 | 2004 | 98 | 0.130 |
Why?
| Plasmids | 5 | 2006 | 360 | 0.130 |
Why?
| Tetrahydrofolate Dehydrogenase | 1 | 2016 | 23 | 0.130 |
Why?
| Drosophila Proteins | 2 | 2003 | 187 | 0.130 |
Why?
| Protein Domains | 1 | 2017 | 254 | 0.120 |
Why?
| Neoplasms | 3 | 2021 | 2454 | 0.120 |
Why?
| Receptors, Progesterone | 1 | 2017 | 341 | 0.120 |
Why?
| HIV-1 | 2 | 1998 | 838 | 0.120 |
Why?
| CRISPR-Cas Systems | 1 | 2016 | 109 | 0.120 |
Why?
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 284 | 0.110 |
Why?
| Proto-Oncogene Proteins | 3 | 1988 | 634 | 0.110 |
Why?
| Receptors, Estrogen | 1 | 2017 | 422 | 0.110 |
Why?
| Escherichia coli Proteins | 1 | 2016 | 179 | 0.110 |
Why?
| Immunoglobulin M | 1 | 2015 | 276 | 0.110 |
Why?
| Granulomatous Disease, Chronic | 2 | 1991 | 53 | 0.110 |
Why?
| Histone Chaperones | 1 | 2013 | 15 | 0.110 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 35 | 0.110 |
Why?
| Cyclin-Dependent Kinase 9 | 2 | 2012 | 10 | 0.110 |
Why?
| Lymphocytes | 1 | 2015 | 377 | 0.110 |
Why?
| Breast Neoplasms | 4 | 2017 | 2104 | 0.100 |
Why?
| Antibodies | 4 | 2006 | 399 | 0.100 |
Why?
| Cytidine Deaminase | 1 | 2013 | 57 | 0.100 |
Why?
| Chloramphenicol O-Acetyltransferase | 3 | 1997 | 38 | 0.100 |
Why?
| Cystadenocarcinoma, Serous | 1 | 2013 | 68 | 0.100 |
Why?
| DNA, Neoplasm | 1 | 2013 | 154 | 0.100 |
Why?
| Cell Line, Tumor | 5 | 2014 | 3184 | 0.100 |
Why?
| Globins | 3 | 1997 | 21 | 0.100 |
Why?
| Sequence Deletion | 2 | 2003 | 179 | 0.090 |
Why?
| Ovary | 1 | 2013 | 209 | 0.090 |
Why?
| Escherichia coli | 1 | 2016 | 766 | 0.090 |
Why?
| Carcinogenesis | 1 | 2013 | 214 | 0.090 |
Why?
| beta-Globins | 1 | 2011 | 8 | 0.090 |
Why?
| Proto-Oncogene Proteins c-myc | 3 | 2009 | 129 | 0.090 |
Why?
| Ribonucleoproteins, Small Nuclear | 1 | 2011 | 22 | 0.090 |
Why?
| DNA | 6 | 2005 | 1406 | 0.090 |
Why?
| Protein Interaction Mapping | 1 | 2012 | 107 | 0.090 |
Why?
| Plasma | 1 | 2013 | 206 | 0.090 |
Why?
| Repetitive Sequences, Amino Acid | 2 | 2001 | 17 | 0.090 |
Why?
| Recombinant Proteins | 4 | 1998 | 1310 | 0.090 |
Why?
| Chromatography, Affinity | 2 | 2002 | 83 | 0.090 |
Why?
| Isoquinolines | 2 | 2004 | 42 | 0.090 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 1990 | 17 | 0.090 |
Why?
| Time Factors | 4 | 2017 | 6545 | 0.090 |
Why?
| DNA Helicases | 3 | 1997 | 146 | 0.090 |
Why?
| Genes, Reporter | 2 | 2003 | 266 | 0.080 |
Why?
| RNA, Untranslated | 1 | 2011 | 117 | 0.080 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2010 | 91 | 0.080 |
Why?
| Chromosome Deletion | 4 | 1992 | 103 | 0.080 |
Why?
| Hepatitis Delta Virus | 1 | 2009 | 7 | 0.080 |
Why?
| Adenosine Deaminase | 2 | 2007 | 29 | 0.080 |
Why?
| Fluorouracil | 1 | 2010 | 197 | 0.080 |
Why?
| Cricetulus | 1 | 2009 | 107 | 0.080 |
Why?
| CHO Cells | 1 | 2009 | 155 | 0.080 |
Why?
| Positive Transcriptional Elongation Factor B | 2 | 2017 | 29 | 0.080 |
Why?
| Deoxycytidine | 1 | 2010 | 164 | 0.080 |
Why?
| Fibronectins | 3 | 2009 | 127 | 0.080 |
Why?
| Epithelial Cells | 1 | 2015 | 1063 | 0.080 |
Why?
| Cricetinae | 1 | 2009 | 280 | 0.080 |
Why?
| rho GTP-Binding Proteins | 1 | 2009 | 60 | 0.080 |
Why?
| RNA Transport | 1 | 2008 | 23 | 0.080 |
Why?
| Active Transport, Cell Nucleus | 1 | 2008 | 113 | 0.070 |
Why?
| Rabbits | 2 | 2002 | 778 | 0.070 |
Why?
| Drug Resistance, Neoplasm | 1 | 2013 | 752 | 0.070 |
Why?
| Ribonucleoproteins | 1 | 2008 | 87 | 0.070 |
Why?
| Phosphoproteins | 1 | 1990 | 333 | 0.070 |
Why?
| Amanitins | 2 | 2004 | 4 | 0.070 |
Why?
| tat Gene Products, Human Immunodeficiency Virus | 2 | 1998 | 23 | 0.070 |
Why?
| Bacteroides | 1 | 2007 | 19 | 0.070 |
Why?
| Enzyme Activation | 2 | 2020 | 812 | 0.070 |
Why?
| Mutant Proteins | 1 | 2007 | 100 | 0.070 |
Why?
| Fragile X Mental Retardation Protein | 1 | 2007 | 56 | 0.070 |
Why?
| Cell Nucleus Structures | 1 | 2006 | 3 | 0.060 |
Why?
| Fragile X Syndrome | 1 | 2007 | 82 | 0.060 |
Why?
| Replication Origin | 2 | 2002 | 17 | 0.060 |
Why?
| Heterozygote | 1 | 2007 | 271 | 0.060 |
Why?
| Oncogenes | 1 | 1986 | 110 | 0.060 |
Why?
| Receptors, AMPA | 1 | 2007 | 137 | 0.060 |
Why?
| Allosteric Regulation | 1 | 2006 | 94 | 0.060 |
Why?
| Substrate Specificity | 2 | 1997 | 371 | 0.060 |
Why?
| Uracil | 1 | 2005 | 31 | 0.060 |
Why?
| DNA Repair | 2 | 1997 | 210 | 0.060 |
Why?
| Glycoproteins | 1 | 2007 | 338 | 0.060 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2004 | 16 | 0.060 |
Why?
| Physical Chromosome Mapping | 1 | 2004 | 17 | 0.060 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2004 | 18 | 0.060 |
Why?
| Genes, cdc | 1 | 2004 | 10 | 0.060 |
Why?
| Sequence Analysis, DNA | 3 | 2004 | 778 | 0.060 |
Why?
| Oligodeoxyribonucleotides | 2 | 1996 | 139 | 0.050 |
Why?
| Genetic Testing | 1 | 2007 | 422 | 0.050 |
Why?
| Genome-Wide Association Study | 1 | 2010 | 1326 | 0.050 |
Why?
| Intestines | 1 | 2007 | 349 | 0.050 |
Why?
| Antineoplastic Agents | 2 | 2013 | 2044 | 0.050 |
Why?
| BRCA2 Protein | 1 | 2003 | 54 | 0.050 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2024 | 156 | 0.050 |
Why?
| RNA, Small Nuclear | 1 | 2003 | 35 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2007 | 569 | 0.050 |
Why?
| Amino Acid Motifs | 1 | 2003 | 215 | 0.050 |
Why?
| Colorectal Neoplasms | 1 | 2010 | 748 | 0.050 |
Why?
| Simian virus 40 | 1 | 2002 | 23 | 0.050 |
Why?
| Tumor Cells, Cultured | 2 | 2017 | 930 | 0.050 |
Why?
| Binding Sites, Antibody | 1 | 1982 | 42 | 0.050 |
Why?
| Structure-Activity Relationship | 1 | 2003 | 547 | 0.050 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2002 | 32 | 0.050 |
Why?
| Operon | 1 | 1982 | 64 | 0.050 |
Why?
| Immunoglobulin Variable Region | 1 | 1982 | 79 | 0.050 |
Why?
| Carcinoma | 1 | 2003 | 213 | 0.050 |
Why?
| Genomics | 3 | 2013 | 716 | 0.050 |
Why?
| Female | 13 | 2017 | 68751 | 0.050 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1560 | 0.050 |
Why?
| Ribonucleases | 2 | 2003 | 54 | 0.050 |
Why?
| Human Genome Project | 1 | 2001 | 15 | 0.050 |
Why?
| Templates, Genetic | 2 | 1996 | 61 | 0.040 |
Why?
| HL-60 Cells | 1 | 2020 | 33 | 0.040 |
Why?
| Cells, Cultured | 2 | 2007 | 4102 | 0.040 |
Why?
| DNA, Plant | 1 | 1999 | 12 | 0.040 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 1999 | 28 | 0.040 |
Why?
| Minichromosome Maintenance Complex Component 2 | 1 | 1999 | 4 | 0.040 |
Why?
| Fatigue | 1 | 2002 | 319 | 0.040 |
Why?
| Genes, Plant | 1 | 1999 | 47 | 0.040 |
Why?
| Holoenzymes | 1 | 1999 | 22 | 0.040 |
Why?
| RNA Helicases | 1 | 1999 | 24 | 0.040 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2002 | 247 | 0.040 |
Why?
| Mammals | 2 | 1998 | 274 | 0.040 |
Why?
| Arabidopsis | 1 | 1999 | 85 | 0.040 |
Why?
| Evolution, Molecular | 3 | 2013 | 462 | 0.040 |
Why?
| Carrier Proteins | 2 | 2003 | 741 | 0.040 |
Why?
| Proteins | 3 | 2004 | 944 | 0.040 |
Why?
| Gene Expression Profiling | 2 | 2017 | 1686 | 0.040 |
Why?
| Cell Differentiation | 1 | 1986 | 1900 | 0.040 |
Why?
| Dogs | 1 | 1999 | 385 | 0.040 |
Why?
| Enhancer Elements, Genetic | 2 | 2002 | 177 | 0.040 |
Why?
| Peptide Initiation Factors | 1 | 1997 | 17 | 0.040 |
Why?
| Eukaryotic Initiation Factor-4E | 1 | 1997 | 27 | 0.040 |
Why?
| Peptide Fragments | 3 | 1998 | 695 | 0.040 |
Why?
| Exercise Therapy | 1 | 2002 | 412 | 0.040 |
Why?
| Tretinoin | 2 | 1990 | 121 | 0.040 |
Why?
| Mediator Complex | 1 | 1998 | 57 | 0.040 |
Why?
| Glutathione Transferase | 1 | 1997 | 102 | 0.040 |
Why?
| Nucleic Acid Hybridization | 2 | 1992 | 188 | 0.030 |
Why?
| Alleles | 2 | 2013 | 843 | 0.030 |
Why?
| Burkitt Lymphoma | 2 | 1988 | 56 | 0.030 |
Why?
| Spodoptera | 1 | 1997 | 37 | 0.030 |
Why?
| Drosophila | 1 | 1998 | 141 | 0.030 |
Why?
| Cell Survival | 1 | 2020 | 1086 | 0.030 |
Why?
| Xeroderma Pigmentosum Group D Protein | 1 | 1996 | 6 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 2001 | 110 | 0.030 |
Why?
| Mice, SCID | 1 | 2017 | 350 | 0.030 |
Why?
| Sp1 Transcription Factor | 1 | 1996 | 24 | 0.030 |
Why?
| Lymphatic Metastasis | 1 | 2017 | 320 | 0.030 |
Why?
| Mutagenesis, Insertional | 1 | 1996 | 64 | 0.030 |
Why?
| Herpes Simplex Virus Protein Vmw65 | 1 | 1995 | 6 | 0.030 |
Why?
| Cloning, Molecular | 2 | 1990 | 524 | 0.030 |
Why?
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1995 | 28 | 0.030 |
Why?
| Mice, Inbred NOD | 1 | 2017 | 587 | 0.030 |
Why?
| Simplexvirus | 1 | 1995 | 80 | 0.030 |
Why?
| Apoptosis | 2 | 2017 | 2489 | 0.030 |
Why?
| Estrogens | 1 | 2017 | 348 | 0.030 |
Why?
| Oligonucleotide Probes | 1 | 1994 | 49 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2017 | 808 | 0.030 |
Why?
| TATA Box | 1 | 1994 | 24 | 0.030 |
Why?
| Blotting, Western | 1 | 1997 | 1204 | 0.030 |
Why?
| Histone Deacetylase 1 | 1 | 2014 | 24 | 0.030 |
Why?
| Granulosa Cell Tumor | 1 | 2013 | 5 | 0.030 |
Why?
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 26 | 0.030 |
Why?
| Time-Lapse Imaging | 1 | 2013 | 20 | 0.030 |
Why?
| Minor Histocompatibility Antigens | 1 | 2013 | 46 | 0.030 |
Why?
| Mediator Complex Subunit 1 | 1 | 2013 | 4 | 0.030 |
Why?
| Retinoblastoma Protein | 1 | 2013 | 53 | 0.030 |
Why?
| Piperazines | 1 | 1995 | 339 | 0.030 |
Why?
| Hyperplasia | 1 | 2013 | 175 | 0.030 |
Why?
| Molecular Weight | 2 | 1990 | 330 | 0.030 |
Why?
| HIV | 1 | 1994 | 227 | 0.030 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 81 | 0.030 |
Why?
| Genetics, Medical | 2 | 2004 | 24 | 0.030 |
Why?
| Multimodal Imaging | 1 | 2013 | 110 | 0.020 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 317 | 0.020 |
Why?
| Gene Duplication | 2 | 2004 | 67 | 0.020 |
Why?
| CpG Islands | 2 | 2004 | 152 | 0.020 |
Why?
| Immunoblotting | 1 | 2012 | 306 | 0.020 |
Why?
| Exome | 1 | 2013 | 216 | 0.020 |
Why?
| Tomography, Optical Coherence | 1 | 2013 | 186 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2013 | 379 | 0.020 |
Why?
| Plant Proteins | 2 | 2003 | 89 | 0.020 |
Why?
| Cytochrome b Group | 1 | 1991 | 18 | 0.020 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 373 | 0.020 |
Why?
| X Chromosome | 1 | 1991 | 50 | 0.020 |
Why?
| Dinucleoside Phosphates | 1 | 1991 | 26 | 0.020 |
Why?
| Genes, Recessive | 1 | 1991 | 76 | 0.020 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 362 | 0.020 |
Why?
| Biomarkers, Tumor | 1 | 2017 | 1161 | 0.020 |
Why?
| Organoplatinum Compounds | 1 | 2010 | 41 | 0.020 |
Why?
| Capecitabine | 1 | 2010 | 45 | 0.020 |
Why?
| Up-Regulation | 1 | 2013 | 836 | 0.020 |
Why?
| Intracellular Membranes | 1 | 1990 | 83 | 0.020 |
Why?
| NADPH Oxidases | 1 | 1990 | 108 | 0.020 |
Why?
| Point Mutation | 2 | 2003 | 224 | 0.020 |
Why?
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 1049 | 0.020 |
Why?
| Cell Proliferation | 1 | 2017 | 2378 | 0.020 |
Why?
| ErbB Receptors | 1 | 2013 | 605 | 0.020 |
Why?
| Fluorescence Recovery After Photobleaching | 1 | 2009 | 19 | 0.020 |
Why?
| Binding, Competitive | 1 | 1989 | 206 | 0.020 |
Why?
| Kidney | 1 | 1996 | 1383 | 0.020 |
Why?
| DNA Restriction Enzymes | 1 | 1988 | 52 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2010 | 610 | 0.020 |
Why?
| Peptide Chain Initiation, Translational | 1 | 1988 | 42 | 0.020 |
Why?
| Protein Biosynthesis | 2 | 1988 | 406 | 0.020 |
Why?
| Translocation, Genetic | 1 | 1987 | 92 | 0.020 |
Why?
| Trinucleotide Repeat Expansion | 1 | 2007 | 27 | 0.020 |
Why?
| Nucleic Acid Amplification Techniques | 1 | 2007 | 32 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 756 | 0.020 |
Why?
| DNA Damage | 1 | 2009 | 383 | 0.020 |
Why?
| Deoxyribonucleases | 1 | 1986 | 23 | 0.020 |
Why?
| Antibodies, Phospho-Specific | 1 | 2006 | 1 | 0.020 |
Why?
| Symbiosis | 1 | 2007 | 71 | 0.020 |
Why?
| Lung Neoplasms | 2 | 2013 | 2343 | 0.020 |
Why?
| Gene Deletion | 1 | 2007 | 380 | 0.020 |
Why?
| Lymphoma | 1 | 1986 | 198 | 0.010 |
Why?
| Neutrophils | 1 | 1990 | 1209 | 0.010 |
Why?
| Contig Mapping | 1 | 2004 | 10 | 0.010 |
Why?
| Pseudogenes | 1 | 2004 | 18 | 0.010 |
Why?
| Adult | 3 | 2017 | 35607 | 0.010 |
Why?
| Base Composition | 1 | 2004 | 76 | 0.010 |
Why?
| Pan troglodytes | 1 | 2004 | 58 | 0.010 |
Why?
| Leukocytes, Mononuclear | 1 | 2007 | 546 | 0.010 |
Why?
| Co-Repressor Proteins | 1 | 2003 | 18 | 0.010 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2003 | 56 | 0.010 |
Why?
| Adenovirus E1A Proteins | 1 | 2003 | 11 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 266 | 0.010 |
Why?
| Gene Amplification | 1 | 2003 | 103 | 0.010 |
Why?
| Antigens, Polyomavirus Transforming | 1 | 2002 | 18 | 0.010 |
Why?
| Gene Silencing | 1 | 2003 | 190 | 0.010 |
Why?
| Adenoviridae | 1 | 2003 | 193 | 0.010 |
Why?
| Nucleic Acid Conformation | 1 | 2006 | 706 | 0.010 |
Why?
| COS Cells | 1 | 2002 | 186 | 0.010 |
Why?
| Microscopy, Immunoelectron | 1 | 2002 | 42 | 0.010 |
Why?
| HT29 Cells | 1 | 2002 | 36 | 0.010 |
Why?
| Schizosaccharomyces pombe Proteins | 1 | 2002 | 49 | 0.010 |
Why?
| Immunoglobulin Light Chains | 1 | 1982 | 40 | 0.010 |
Why?
| Gene Expression Regulation, Viral | 1 | 2002 | 90 | 0.010 |
Why?
| Protein Isoforms | 1 | 2003 | 393 | 0.010 |
Why?
| Ecosystem | 1 | 2007 | 561 | 0.010 |
Why?
| Drosophila melanogaster | 1 | 2003 | 211 | 0.010 |
Why?
| Bacteriophage lambda | 1 | 1982 | 88 | 0.010 |
Why?
| GC Rich Sequence | 1 | 2001 | 4 | 0.010 |
Why?
| Public Sector | 1 | 2001 | 17 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 953 | 0.010 |
Why?
| B-Lymphocytes | 1 | 1986 | 816 | 0.010 |
Why?
| Private Sector | 1 | 2001 | 50 | 0.010 |
Why?
| DNA Replication | 1 | 2002 | 225 | 0.010 |
Why?
| Microscopy, Confocal | 1 | 2002 | 318 | 0.010 |
Why?
| Bacterial Proteins | 1 | 2007 | 838 | 0.010 |
Why?
| Genetic Diseases, Inborn | 1 | 2001 | 36 | 0.010 |
Why?
| Physical Fitness | 1 | 2002 | 203 | 0.010 |
Why?
| Conserved Sequence | 1 | 2001 | 227 | 0.010 |
Why?
| Disability Evaluation | 1 | 2002 | 285 | 0.010 |
Why?
| DNA Transposable Elements | 1 | 2001 | 119 | 0.010 |
Why?
| Respiratory Function Tests | 1 | 2002 | 581 | 0.010 |
Why?
| Phylogeny | 1 | 2003 | 845 | 0.010 |
Why?
| Chromosome Mapping | 1 | 2001 | 499 | 0.010 |
Why?
| Drug Industry | 1 | 2001 | 106 | 0.010 |
Why?
| Species Specificity | 1 | 2001 | 568 | 0.010 |
Why?
| Heterochromatin | 1 | 1999 | 43 | 0.010 |
Why?
| Homeodomain Proteins | 1 | 2003 | 493 | 0.010 |
Why?
| Leukemia, Myeloid, Acute | 1 | 1986 | 596 | 0.010 |
Why?
| Chromosomes | 1 | 1999 | 99 | 0.010 |
Why?
| Regression Analysis | 1 | 2002 | 997 | 0.010 |
Why?
| Multigene Family | 1 | 1999 | 195 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 371 | 0.010 |
Why?
| Forecasting | 1 | 2001 | 361 | 0.010 |
Why?
| Genetic Variation | 1 | 2004 | 937 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 2014 | 0.010 |
Why?
| Oxygen Consumption | 1 | 2002 | 672 | 0.010 |
Why?
| Exercise Test | 1 | 2002 | 614 | 0.010 |
Why?
| Quality of Life | 1 | 2010 | 2694 | 0.010 |
Why?
| Cloning, Organism | 1 | 1998 | 6 | 0.010 |
Why?
| Protein Sorting Signals | 1 | 1998 | 19 | 0.010 |
Why?
| Genetic Complementation Test | 1 | 1998 | 64 | 0.010 |
Why?
| Cations, Divalent | 1 | 1998 | 53 | 0.010 |
Why?
| Guanosine Triphosphate | 1 | 1998 | 92 | 0.010 |
Why?
| Heart Rate | 1 | 2002 | 803 | 0.010 |
Why?
| Fetus | 1 | 1982 | 776 | 0.010 |
Why?
| Mutagenesis, Site-Directed | 1 | 1998 | 363 | 0.010 |
Why?
| Rats | 1 | 2006 | 5485 | 0.010 |
Why?
| Protein Conformation | 1 | 1999 | 861 | 0.010 |
Why?
| Proteome | 1 | 2001 | 440 | 0.010 |
Why?
| Databases, Factual | 1 | 2001 | 1269 | 0.010 |
Why?
| Prognosis | 1 | 2003 | 3772 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2003 | 2271 | 0.010 |
Why?
| Liver | 1 | 1982 | 1839 | 0.010 |
Why?
| Restriction Mapping | 1 | 1991 | 74 | 0.010 |
Why?
| Aged | 1 | 2010 | 22101 | 0.010 |
Why?
| Exercise | 1 | 2002 | 1933 | 0.010 |
Why?
| Prospective Studies | 1 | 2002 | 7145 | 0.010 |
Why?
| Pregnancy | 1 | 1982 | 6412 | 0.000 |
Why?
| Reference Values | 1 | 1991 | 796 | 0.000 |
Why?
| Middle Aged | 1 | 2010 | 31165 | 0.000 |
Why?
| DNA, Recombinant | 1 | 1988 | 46 | 0.000 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 1987 | 19 | 0.000 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 1987 | 28 | 0.000 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 1987 | 40 | 0.000 |
Why?
| Chromosomes, Human, Pair 8 | 1 | 1987 | 36 | 0.000 |
Why?
| Codon | 1 | 1988 | 84 | 0.000 |
Why?
| Chickens | 1 | 1988 | 188 | 0.000 |
Why?
| Biological Evolution | 1 | 1988 | 435 | 0.000 |
Why?
| Male | 1 | 2010 | 63691 | 0.000 |
Why?
|
|
Bentley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|